Cladribine (2-CdA, Leustat)

Cladribine (2-CdA, Leustat)

This patient-friendly article is about chemotherapy drug, Cladribine (2-CdA, Leustat) which is a chemotherapy drug that is given mainly as a treatment for hairy cell leukaemia and CLL (chronic lymphocytic leukaemia). For the hairy cell leukaemia it is administered intravenously, sometimes as a continuous infusion through a fixed line into your body delivered via a small portable pump. 

Side effects can include: lowered resistance to infection, bruising or bleeding, anaemia, nausea and vomiting, rashes. Less common are changes in liver and kidney function, neurological changes and fever.

Approved by

the Medical Board. 

Click Here







Go to: 10 ways to improve your chemotherapy success and reduce side-effects

Other articles that you may find interesting are:

  1. A diet for Chemotherapy
  2. Immunotherapy overview
  3. A to Z Guide to Complementary Therapies

Go to: Return to the CANCERactive drug list

Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Chris'

Join Chris' NewsletterSignup today for free and be the first to get notified on new updates.